supplemental figure from Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer

Autor: Federico Innocenti, Gianna Tabaro, Gianmaria Miolo, Blase N. Polite, Angela Buonadonna, Quan Mai, Elizabeth Gray, Bianca Posocco, Elena Marangon, Manish R. Sharma, Giuseppe Toffoli
Rok vydání: 2023
DOI: 10.1158/1078-0432.22467224.v1
Popis: Supplementary Figure 1. Progression-free survival (PFS) overall (A), by UGT1A1 genotype (B), and by irinotecan dose (C).
Databáze: OpenAIRE